Australian and New Zealand national evidence-based recommendations for the investigation and follow-up of undifferentiated peripheral inflammatory arthritis: an integration of systematic literature research and rheumatological expert opinion

2013 ◽  
Vol 16 (6) ◽  
pp. 637-651 ◽  
Author(s):  
Claire Barrett ◽  
Paul Bird ◽  
Gabor Major ◽  
Evange Romas ◽  
Ian Portek ◽  
...  
Keyword(s):  
New Zealand ◽  
Expert Opinion ◽  
Inflammatory Arthritis ◽  
Evidence Based ◽  
Literature Research

Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis

2014 ◽  
Vol 17 (7) ◽  
pp. 738-748 ◽  
Author(s):  
Bethan L. Richards ◽  
Samuel Whittle ◽  
Rachelle Buchbinder ◽  
Claire Barrett ◽  
Nora Lynch ◽  
...  
Keyword(s):  
New Zealand ◽  
Pain Management ◽  
Inflammatory Arthritis ◽  
Adult Patients ◽  
Evidence Based

scholarly journals Marine Debris on New Zealand Beaches - Baseline Data to Evaluate Regional Variances

2021 ◽  
Vol 9 ◽  
Author(s):  
Ella van Gool ◽  
Marnie Campbell ◽  
Pip Wallace ◽  
Chad L. Hewitt
Keyword(s):  
New Zealand ◽  
Population Density ◽  
Marine Debris ◽  
Evidence Based ◽  
Spatial Variance ◽  
The North ◽  
Starting Point ◽  
Follow Up Studies ◽  
North And South

Terrestrial sources of marine debris on beaches are substantial, increasing, and are primarily a result of mismanaged waste on land. The scale, source, and composition of beached marine debris in New Zealand was determined by surveying 41 beaches, with triplicate belt transects, across the North and South Islands. Results demonstrated a significant spatial variance, with the South Island showing a significantly higher mean density than the more populated North Island by count as well as by weight. The majority of all anthropogenic marine debris detected was plastic and arrived through the water. Explanations for regional variances in debris presence are difficult to ascertain with certainty but could not be explained by population density and proximity. These findings contribute to the understudied field of marine debris research in New Zealand and the Southern Hemisphere and provide a starting point for evidence-based mitigation. Recommended changes to future monitoring programs are made. This first national baseline study of marine debris in New Zealand serves as a reference for follow-up studies, including research at other locations.

scholarly journals EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

2009 ◽  
Vol 69 (2) ◽  
pp. 325-331 ◽  
Author(s):  
M J L Peters ◽  
D P M Symmons ◽  
D McCarey ◽  
B A C Dijkmans ◽  
P Nicola ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Risk Management ◽  
Inflammatory Arthritis ◽  
Task Force ◽  
Score Function ◽  
Cochrane Library ◽  
Expert Committee ◽  
Evidence Based ◽  
National Guidelines ◽  
Literature Research

Objectives:To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA).Methods:A multidisciplinary expert committee was convened as a task force of the EULAR Standing Committee for Clinical Affairs (ESCCA), comprising 18 members including rheumatologists, cardiologists, internists and epidemiologists, representing nine European countries. Problem areas and related keywords for systematic literature research were identified. A systematic literature research was performed using MedLine, Embase and the Cochrane library through to May 2008. Based on this literature review and in accordance with the EULAR’s “standardised operating procedures”, the multidisciplinary steering committee formulated evidence-based and expert opinion-based recommendations for CV risk screening and management in patients with inflammatory arthritis.Results:Annual CV risk assessment using national guidelines is recommended for all patients with RA and should be considered for all patients with AS and PsA. Any CV risk factors identified should be managed according to local guidelines. If no local guidelines are available, CV risk management should be carried out according to the SCORE function. In addition to appropriate CV risk management, aggressive suppression of the inflammatory process is recommended to further lower the CV risk.Conclusions:Ten recommendations were made for CV risk management in patients with RA, AS and PsA. The strength of the recommendations differed between RA on the one hand, and AS and PsA, on the other, as evidence for an increased CV risk is most compelling for RA.

What Does Evidence-Based Practice Mean to You? A Follow-Up Study Examining School-Based Speech-Language Pathologists' Perspectives on Evidence-Based Practice

2020 ◽  
Vol 29 (2) ◽  
pp. 688-704
Author(s):  
Katrina Fulcher-Rood ◽  
Anny Castilla-Earls ◽  
Jeff Higginbotham
Keyword(s):  
Clinical Practice ◽  
Research Evidence ◽  
Evidence Based Practice ◽  
Evidence Based ◽  
Clinical Expertise ◽  
Speech Language Pathologists ◽  
School Based ◽  
Research Findings ◽  
Ebp Implementation

Purpose The current investigation is a follow-up from a previous study examining child language diagnostic decision making in school-based speech-language pathologists (SLPs). The purpose of this study was to examine the SLPs' perspectives regarding the use of evidence-based practice (EBP) in their clinical work. Method Semistructured phone interviews were conducted with 25 school-based SLPs who previously participated in an earlier study by Fulcher-Rood et al. 2018). SLPs were asked questions regarding their definition of EBP, the value of research evidence, contexts in which they implement scientific literature in clinical practice, and the barriers to implementing EBP. Results SLPs' definitions of EBP differed from current definitions, in that SLPs only included the use of research findings. SLPs seem to discuss EBP as it relates to treatment and not assessment. Reported barriers to EBP implementation were insufficient time, limited funding, and restrictions from their employment setting. SLPs found it difficult to translate research findings to clinical practice. SLPs implemented external research evidence when they did not have enough clinical expertise regarding a specific client or when they needed scientific evidence to support a strategy they used. Conclusions SLPs appear to use EBP for specific reasons and not for every clinical decision they make. In addition, SLPs rely on EBP for treatment decisions and not for assessment decisions. Educational systems potentially present other challenges that need to be considered for EBP implementation. Considerations for implementation science and the research-to-practice gap are discussed.

Eine Therapie mit Everolimus und reduziertem Ciclosporin kann das Krebsrisiko von Nierentransplantierten verringern* (Sponsor: Novartis Pharma GmbH, Nürnberg)

2017 ◽  
Vol 05 (01) ◽  
pp. 22-22
Keyword(s):  
New Zealand ◽  
De Novo

ZusammenfassungDie Verknüpfung der A2309-Studie mit dem Australia and New Zealand Dialysis and Transplant (ANZDATA) Register erlaubte ein Follow up von 7 Jahren. Die Autoren bezeichnen diese Analyse als die bisher überzeugendste Evidenz, dass eine Immunsuppression mit de novo Everolimus und reduziertem Ciclosporin langfristig mit einer geringeren Krebsinzidenz nach Nierentransplantation assoziiert ist als die Standardtherapie.

Sign in / Sign up

Export Citation Format

Share Document